Quest Diagnostics Launches 88-Compound Novel Psychoactive Substance Test Panel
The new panel from Quest tests for 88 compounds, and covers a broad array of drug classes, and other illicit additives.
Read More
Search Results for: point-of-care
Made-to-Order Diagnostic Tests May be on the Horizon
Researchers developed new lab-on-a-chip diagnostic technology that has the potential to make on-the-spot tests widely accessible.
Read More
Ad Astra Diagnostics’ Hematology Analyzer Gets 510(k) Clearance
The hematology analyzer provides patient-side results to screen for conditions including infection, leukemia, and other blood-related cancers.
Read More
Inflammatix Acute Infection and Sepsis Test System Gets FDA Breakthrough Device Designation
Inflammatix says that the U.S. FDA has granted Breakthrough Device Designation for its TriVerity Acute Infection and Sepsis Test System.
Read More
Understanding Latent Tuberculosis Diagnosis
Though without a standard TB diagnosis, guidelines recommend the use of either the TST or IGRAs to test for latent tuberculosis infections.
Read More